IP Library Granted Patent US 11,959,140
Granted Patent B2
US 11,959,140 · App. 16/975,840 · Granted Apr 16, 2024

Method for monitoring metabolism before and after exercise or injury using salivary micro-RNAs

Inventors: Richard Uhlig (Ithaca, NY); Steven D. Hicks (Hershey, PA); Frank A. Middleton (Fayetteville, NY)
Assignees: QUADRANT BIOSCIENCES INC.; PENN STATE RESEARCH FOUNDATION; THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
C12Q1/6883C12Q2600/178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,959,140
App. No.
16/975,840
Granted
Apr 16, 2024
Kind
B2
Abstract

A method for evaluating or monitoring metabolic effects of exercise or injury by detecting and/or quantifying microR-NAs in saliva. Compositions and methods of treatment based on detection of microRNAs.

Claims (13)

1. A method for selecting an injury recovery exercise regimen for a subject having a concussion or traumatic brain injury (TBI) comprising:

detecting pre-exercise levels of miR-7154-3p, miR-200b-5p, miR-5582-3p, miR-6859-3p, miR-6751-5p, and miR-4419a in a saliva sample obtained from the subject having the concussion or TBI,

administering an injury recovery exercise regimen to said subject,

detecting post-exercise levels of miR-7154-3p, miR-200b-5p, miR-5582-3p, miR-6859-3p, miR-6751-5p, and miR-4419a in a saliva sample obtained from the subject;

selecting the injury recovery regimen for said subject when the post-exercise levels of miR-7154-3p, miR-200b-5p, miR-5582-3p, miR-6859-3p, miR-6751-5p, and miR-4419a are increased in comparison to the pre-exercise levels of miR-7154-3p, miR-200b-5p, miR-5582-3p, miR-6859-3p, miR-6751-5p, and miR-4419a; and

continuing to administer the selected injury recovery exercise regimen to said subject.

2. The method of claim 1 , further comprising detecting pre-exercise levels of miR-3671 and/or miR-5095 in the saliva sample obtained from the subject and detecting post exercise levels of miR-3671 and/or miR-5095 in the saliva sample obtained from the subject.

3. The method of claim 1 , wherein the subject has had a concussion.

4. The method of claim 1 , wherein the subject has had a TBI.

5. The method of claim 1 , wherein the regimen comprises aerobic exercise.

6. The method of claim 1 , wherein the regimen comprises jogging or running.

7. The method of claim 1 , wherein the regimen comprises a sports training regimen.

8. The method of claim 1 , wherein the regimen further comprises a health or weight loss regimen.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 17, 2026
From: NEUROSPINE VENTURES XXXIX LLC
To: QUADRANT BIOSCIENCES (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 074105/0342 →
SECURITY INTEREST Recorded Aug 14, 2024
From: QUADRANT BIOSCIENCES (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: NEUROSPINE VENTURES XXXIX LLC
Reel/Frame 068281/0431 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2021
From: UHLIG, RICHARD; HICKS, STEVEN D.; MIDDLETON, FRANK A.
To: QUADRANT BIOSCIENCES INC.; PENN STATE RESEARCH FOUNDATION; THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Reel/Frame 057917/0146 →
CONFIRMATORY LICENSE Recorded Oct 5, 2020
From: PENNSYLVANIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 053978/0865 →
Continuity (2)
Provisional Application 62635729 · Feb 27, 2018
Related Publication 20200407795A1 · Dec 31, 2020